Home › Companies › TransMedics Group, Inc. › 2025-2026

TransMedics Group, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and TransMedics Group, Inc.’s Form 8-K, filed May 21, 2026 (Item 5.07 on EDGAR). Page generated October 25, 2026.

  • 11Ballot items
  • 433Asset managers
  • 5,001Fund votes
  • May 20, 2026Meeting date

Results at a glance

Meeting of May 20, 2026: 11 items on TransMedics Group, Inc.’s Form 8-K, filed May 21, 2026: 8 elected · 3 approved.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TransMedics Group, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by TransMedics Group, Inc.

These tallies are TransMedics Group, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 21, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TransMedics Group, Inc. — official shareholder meeting results, meeting held May 20, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Waleed Hassanein, M.D 23,925,335122,99915,389 --4,632,985 99.4%Elected—
Elect Director: James R. Tobin 23,594,322453,10016,301 --4,632,985 98%Elected—
Elect Director: Edward M. Basile 22,395,7871,651,46616,470 --4,632,985 93%Elected—
Elect Director: Thomas J. Gunderson 23,667,347380,23316,143 --4,632,985 98%Elected—
Elect Director: Edwin M. Kania, Jr. 23,603,708443,43816,577 --4,632,985 98%Elected—
Elect Director: Stephanie Lovell 23,932,921111,75719,045 --4,632,985 99.5%Elected—
Elect Director: Merilee Raines 23,908,647140,71514,361 --4,632,985 99.4%Elected—
Elect Director: David Weill, M.D. 23,842,978204,71716,028 --4,632,985 99.1%Elected—
2. On a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes 22,871,6471,161,18130,895 --4,632,985 95%Approved—
3. The amendment to the Amended and Restated TransMedics Group, Inc. 2019 Stock Incentive Plan, based on the following votes 17,265,3696,758,88239,472 --4,632,985 72%Approved—
4. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026, based on the following votes 28,030,696648,35917,653 ---- 98%Approved—

Source: TransMedics Group, Inc., Form 8-K, filed with the SEC on May 21, 2026 — read the filing on EDGAR.

How asset managers voted at the TransMedics Group, Inc. 2025-2026 meeting

Each item below shows how the 433 asset managers that disclosed a TransMedics Group, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: David Weill, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 23,842,978AGAINST: 204,717
Details: description as filed, official tally, votes by 122 asset managers

Description as filed by funds: Election of Directors: David Weill, M.D.

TransMedics Group, Inc.’s own tally for this item (“Elect Director: David Weill, M.D.”): 23,842,978 for, 204,717 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania, Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, …”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 122 asset managers below reported 15,332,634 for, 6,269 against, 6,406 abstained.

FOR
FOR: 15,332,634AGAINST: 6,269ABSTAIN: 6,406
Largest asset managers voting on “Election of Directors: David Weill, M.D.” at TransMedics Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity4,293,6370 00For
Vanguard3,559,0283 00For
BlackRock1,928,2000 00For
MUTUAL FUND SERIES TRUST548,6670 00For
Delaware/Macquarie465,8040 00For
Capital Group300,0040 00For
Charles Schwab278,5180 00For
Royce241,4600 00For
Invesco223,0180 00For
Jackson National194,4640 00For
WASATCH FUNDS TRUST189,8030 00For
T. Rowe Price187,4390 00For
Waddell & Reed175,2560 00For
Hartford153,5870 00For
RBB FUND, INC.148,0040 00For
State Street137,7750 00For
Lord Abbett133,8000 00For
Bridge Builder Trust126,4410 00For
Principal111,7730 00For
Manager Directed Portfolios110,5880 00For
Brighthouse89,8030 6,4060Mixed
Columbia Threadneedle80,6050 00For
Lincoln Financial74,0620 00For
Brown Capital Management Mutual Funds71,3490 00For
TIAA70,7370 00For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

2. Elect Director: Edward M. Basile

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 22,395,787AGAINST: 1,651,466
Details: description as filed, official tally, votes by 122 asset managers

Description as filed by funds: Election of Directors: Edward M. Basile

TransMedics Group, Inc.’s own tally for this item (“Elect Director: Edward M. Basile”): 22,395,787 for, 1,651,466 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania, Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, …”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 122 asset managers below reported 14,469,628 for, 849,275 against, 6,406 abstained.

FOR
FOR: 14,469,628AGAINST: 849,275ABSTAIN: 6,406
Largest asset managers voting on “Election of Directors: Edward M. Basile” at TransMedics Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity4,293,6370 00For
Vanguard3,554,0774,954 00For
BlackRock1,928,2000 00For
MUTUAL FUND SERIES TRUST548,6670 00For
Delaware/Macquarie0465,804 00Against
Capital Group300,0040 00For
Charles Schwab278,5180 00For
Royce241,4600 00For
Invesco223,0180 00For
Jackson National194,4640 00For
WASATCH FUNDS TRUST189,8030 00For
T. Rowe Price187,4390 00For
Waddell & Reed0175,256 00Against
Hartford153,5870 00For
RBB FUND, INC.148,0040 00For
State Street137,7750 00For
Lord Abbett133,8000 00For
Bridge Builder Trust126,4410 00For
Principal111,7730 00For
Manager Directed Portfolios110,5880 00For
Brighthouse89,8030 6,4060Mixed
Columbia Threadneedle080,605 00Against
Lincoln Financial38,86035,202 00Mixed
Brown Capital Management Mutual Funds71,3490 00For
TIAA70,7370 00For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

3. Elect Director: Edwin M. Kania, Jr.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 23,603,708AGAINST: 443,438
Details: description as filed, official tally, votes by 122 asset managers

Description as filed by funds: Election of Directors: Edwin M. Kania, Jr.

TransMedics Group, Inc.’s own tally for this item (“Elect Director: Edwin M. Kania, Jr.”): 23,603,708 for, 443,438 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania, Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, …”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 122 asset managers below reported 15,292,482 for, 26,421 against, 6,406 abstained.

FOR
FOR: 15,292,482AGAINST: 26,421ABSTAIN: 6,406
Largest asset managers voting on “Election of Directors: Edwin M. Kania, Jr.” at TransMedics Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity4,293,6370 00For
Vanguard3,559,0283 00For
BlackRock1,928,2000 00For
MUTUAL FUND SERIES TRUST548,6670 00For
Delaware/Macquarie465,8040 00For
Capital Group300,0040 00For
Charles Schwab278,5180 00For
Royce241,4600 00For
Invesco223,0180 00For
Jackson National194,4640 00For
WASATCH FUNDS TRUST189,8030 00For
T. Rowe Price187,4390 00For
Waddell & Reed175,2560 00For
Hartford153,5870 00For
RBB FUND, INC.148,0040 00For
State Street137,76510 00For
Lord Abbett133,8000 00For
Bridge Builder Trust126,4410 00For
Principal111,7730 00For
Manager Directed Portfolios110,5880 00For
Brighthouse89,8030 6,4060Mixed
Columbia Threadneedle80,6050 00For
Lincoln Financial74,0620 00For
Brown Capital Management Mutual Funds71,3490 00For
TIAA70,7370 00For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

4. Elect Director: James R. Tobin

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 23,594,322AGAINST: 453,100
Details: description as filed, official tally, votes by 122 asset managers

Description as filed by funds: Election of Directors: James R. Tobin

TransMedics Group, Inc.’s own tally for this item (“Elect Director: James R. Tobin”): 23,594,322 for, 453,100 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania, Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, …”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 122 asset managers below reported 15,297,356 for, 21,546 against, 6,406 abstained.

FOR
FOR: 15,297,356AGAINST: 21,546ABSTAIN: 6,406
Largest asset managers voting on “Election of Directors: James R. Tobin” at TransMedics Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity4,293,6370 00For
Vanguard3,554,0864,945 00For
BlackRock1,928,2000 00For
MUTUAL FUND SERIES TRUST548,6670 00For
Delaware/Macquarie465,8040 00For
Capital Group300,0040 00For
Charles Schwab278,5180 00For
Royce241,4600 00For
Invesco223,0180 00For
Jackson National194,4640 00For
WASATCH FUNDS TRUST189,8030 00For
T. Rowe Price187,4390 00For
Waddell & Reed175,2560 00For
Hartford153,5870 00For
RBB FUND, INC.148,0040 00For
State Street137,76510 00For
Lord Abbett133,8000 00For
Bridge Builder Trust126,4410 00For
Principal111,7730 00For
Manager Directed Portfolios110,5880 00For
Brighthouse89,8030 6,4060Mixed
Columbia Threadneedle80,6050 00For
Lincoln Financial74,0620 00For
Brown Capital Management Mutual Funds71,3490 00For
TIAA70,7370 00For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

5. Elect Director: Merilee Raines

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 23,908,647AGAINST: 140,715
Details: description as filed, official tally, votes by 122 asset managers

Description as filed by funds: Election of Directors: Merilee Raines

TransMedics Group, Inc.’s own tally for this item (“Elect Director: Merilee Raines”): 23,908,647 for, 140,715 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania, Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, …”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 122 asset managers below reported 15,312,671 for, 26,232 against, 6,406 abstained.

FOR
FOR: 15,312,671AGAINST: 26,232ABSTAIN: 6,406
Largest asset managers voting on “Election of Directors: Merilee Raines” at TransMedics Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity4,293,6370 00For
Vanguard3,559,0292 00For
BlackRock1,928,2000 00For
MUTUAL FUND SERIES TRUST548,6670 00For
Delaware/Macquarie465,8040 00For
Capital Group300,0040 00For
Charles Schwab278,5180 00For
Royce241,4600 00For
Invesco223,0180 00For
Jackson National194,4640 00For
WASATCH FUNDS TRUST189,8030 00For
T. Rowe Price187,4390 00For
Waddell & Reed175,2560 00For
Hartford153,5870 00For
RBB FUND, INC.148,0040 00For
State Street137,7750 00For
Lord Abbett133,8000 00For
Bridge Builder Trust126,4410 00For
Principal111,7730 00For
Manager Directed Portfolios110,5880 00For
Brighthouse89,8030 6,4060Mixed
Columbia Threadneedle80,6050 00For
Lincoln Financial74,0620 00For
Brown Capital Management Mutual Funds71,3490 00For
TIAA70,7370 00For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

6. Elect Director: Stephanie Lovell

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 23,932,921AGAINST: 111,757
Details: description as filed, official tally, votes by 122 asset managers

Description as filed by funds: Election of Directors: Stephanie Lovell

TransMedics Group, Inc.’s own tally for this item (“Elect Director: Stephanie Lovell”): 23,932,921 for, 111,757 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania, Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, …”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 122 asset managers below reported 15,336,123 for, 2,780 against, 6,406 abstained.

FOR
FOR: 15,336,123AGAINST: 2,780ABSTAIN: 6,406
Largest asset managers voting on “Election of Directors: Stephanie Lovell” at TransMedics Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity4,293,6370 00For
Vanguard3,559,0292 00For
BlackRock1,928,2000 00For
MUTUAL FUND SERIES TRUST548,6670 00For
Delaware/Macquarie465,8040 00For
Capital Group300,0040 00For
Charles Schwab278,5180 00For
Royce241,4600 00For
Invesco223,0180 00For
Jackson National194,4640 00For
WASATCH FUNDS TRUST189,8030 00For
T. Rowe Price187,4390 00For
Waddell & Reed175,2560 00For
Hartford153,5870 00For
RBB FUND, INC.148,0040 00For
State Street137,7750 00For
Lord Abbett133,8000 00For
Bridge Builder Trust126,4410 00For
Principal111,7730 00For
Manager Directed Portfolios110,5880 00For
Brighthouse89,8030 6,4060Mixed
Columbia Threadneedle80,6050 00For
Lincoln Financial74,0620 00For
Brown Capital Management Mutual Funds71,3490 00For
TIAA70,7370 00For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

7. Elect Director: Thomas J. Gunderson

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 23,667,347AGAINST: 380,233
Details: description as filed, official tally, votes by 122 asset managers

Description as filed by funds: Election of Directors: Thomas J. Gunderson

TransMedics Group, Inc.’s own tally for this item (“Elect Director: Thomas J. Gunderson”): 23,667,347 for, 380,233 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania, Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, …”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 122 asset managers below reported 15,292,492 for, 26,411 against, 6,406 abstained.

FOR
FOR: 15,292,492AGAINST: 26,411ABSTAIN: 6,406
Largest asset managers voting on “Election of Directors: Thomas J. Gunderson” at TransMedics Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity4,293,6370 00For
Vanguard3,559,0283 00For
BlackRock1,928,2000 00For
MUTUAL FUND SERIES TRUST548,6670 00For
Delaware/Macquarie465,8040 00For
Capital Group300,0040 00For
Charles Schwab278,5180 00For
Royce241,4600 00For
Invesco223,0180 00For
Jackson National194,4640 00For
WASATCH FUNDS TRUST189,8030 00For
T. Rowe Price187,4390 00For
Waddell & Reed175,2560 00For
Hartford153,5870 00For
RBB FUND, INC.148,0040 00For
State Street137,7750 00For
Lord Abbett133,8000 00For
Bridge Builder Trust126,4410 00For
Principal111,7730 00For
Manager Directed Portfolios110,5880 00For
Brighthouse89,8030 6,4060Mixed
Columbia Threadneedle80,6050 00For
Lincoln Financial74,0620 00For
Brown Capital Management Mutual Funds71,3490 00For
TIAA70,7370 00For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

8. Elect Director: Waleed Hassanein, M.D

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 23,925,335AGAINST: 122,999
Details: description as filed, official tally, votes by 122 asset managers

Description as filed by funds: Election of Directors: Waleed H. Hassanein, M.D.

TransMedics Group, Inc.’s own tally for this item (“Elect Director: Waleed Hassanein, M.D”): 23,925,335 for, 122,999 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania, Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, …”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 122 asset managers below reported 15,318,897 for, 5 against, 6,406 abstained.

FOR
FOR: 15,318,897AGAINST: 5ABSTAIN: 6,406
Largest asset managers voting on “Election of Directors: Waleed H. Hassanein, M.D.” at TransMedics Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity4,293,6370 00For
Vanguard3,559,0310 00For
BlackRock1,928,2000 00For
MUTUAL FUND SERIES TRUST548,6670 00For
Delaware/Macquarie465,8040 00For
Capital Group300,0040 00For
Charles Schwab278,5180 00For
Royce241,4600 00For
Invesco223,0180 00For
Jackson National194,4640 00For
WASATCH FUNDS TRUST189,8030 00For
T. Rowe Price187,4390 00For
Waddell & Reed175,2560 00For
Hartford153,5870 00For
RBB FUND, INC.148,0040 00For
State Street137,7705 00For
Lord Abbett133,8000 00For
Bridge Builder Trust126,4410 00For
Principal111,7730 00For
Manager Directed Portfolios110,5880 00For
Brighthouse89,8030 6,4060Mixed
Columbia Threadneedle80,6050 00For
Lincoln Financial74,0620 00For
Brown Capital Management Mutual Funds71,3490 00For
TIAA70,7370 00For

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

9. 3. The amendment to the Amended and Restated TransMedics Group, Inc. 2019 Stock Incentive Plan, based on the following…

Official resultCOMPENSATIONReported outcome: Approved

Combines 5 wordings of this item as funds reported it.

72% Approved · of votes cast

FOR 72%AGAINST
FOR: 17,265,369AGAINST: 6,758,882
Details: description as filed, official tally, votes by 125 asset managers

Description as filed by funds: To approve an amendment to the TransMedics Group, Inc.'s Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan by 2,750,000 shares and make certain other changes as set forth in the proxy statement.

TransMedics Group, Inc.’s own tally for this item (“3. The amendment to the Amended and Restated TransMedics Group, Inc. 2019 Stock Incentive Plan, based on the following votes”): 17,265,369 for, 6,758,882 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Three : The shareholders approved the amendment to the Amended and Restated TransMedics Group, Inc. 2019 Stock Incentive Plan, based on the following votes:”
Support: 72% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 125 asset managers below reported 11,964,652 for, 3,375,277 against, 6,406 abstained.

FORAGAINST
FOR: 11,964,652AGAINST: 3,375,277ABSTAIN: 6,406
Largest asset managers voting on “To approve an amendment to the TransMedics Group, Inc.'s Amended and Restated 2019 Stock Incentive Plan to inc” at TransMedics Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity4,293,6370 00For
Vanguard3,433,738125,293 00For
BlackRock1,928,2000 00For
MUTUAL FUND SERIES TRUST543,3125,355 00For
Delaware/Macquarie0465,804 00Against
Capital Group300,0040 00For
Charles Schwab0278,518 00Against
Royce0241,460 00Against
Invesco223,0180 00For
Jackson National128,84365,621 00Mixed
WASATCH FUNDS TRUST0189,803 00Against
T. Rowe Price0187,439 00Against
Waddell & Reed0175,256 00Against
Hartford0153,587 00Against
RBB FUND, INC.148,0040 00For
State Street137,553222 00For
Lord Abbett133,8000 00For
Bridge Builder Trust6,406120,035 00Mixed
Principal81,91129,862 00Mixed
Manager Directed Portfolios0110,588 00Against
Brighthouse57,86231,941 6,4060Mixed
Columbia Threadneedle80,6050 00For
Lincoln Financial25,85748,205 00Mixed
Brown Capital Management Mutual Funds071,349 00Against
TIAA70,7370 00For

Showing the 25 largest of 125 asset managers. See all 125 in the interactive database.

10. 2. On a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%
FOR: 22,871,647AGAINST: 1,161,181
Details: description as filed, official tally, votes by 432 asset managers

Description as filed by funds: To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.

TransMedics Group, Inc.’s own tally for this item (“2. On a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes”): 22,871,647 for, 1,161,181 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Two : The shareholders approved, on a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 121 asset managers voting on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.” at TransMedics Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity4,293,6370 00For
Vanguard3,559,0283 00For
BlackRock1,928,2000 00For
MUTUAL FUND SERIES TRUST548,6670 00For
Delaware/Macquarie465,8040 00For
Capital Group300,0040 00For
Charles Schwab278,5180 00For
Royce241,4600 00For
Invesco0223,018 00Against
RBB FUND, INC.200,8710 00For
Jackson National65,621128,843 00Mixed
WASATCH FUNDS TRUST189,8030 00For
T. Rowe Price187,4390 00For
Waddell & Reed175,2560 00For
Hartford153,5870 00For
State Street137,7750 00For
Lord Abbett133,8000 00For
Bridge Builder Trust126,4410 00For
Principal111,7730 00For
Manager Directed Portfolios110,5880 00For
Brighthouse31,94157,862 6,4060Mixed
Columbia Threadneedle80,6050 00For
Lincoln Financial74,0620 00For
Brown Capital Management Mutual Funds71,3490 00For
TIAA70,7370 00For

Fund voting reports, all 121 managers: 14,945,671 for, 441,786 against, 6,406 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 342 asset managers voting on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.” at TransMedics Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity4,318,4990 00For
BlackRock979,655513 00For
GEODE CAPITAL MANAGEMENT, LLC815,5200 00For
NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST792,2040 00For
State Street553,3140 00For
Invesco0456,762 00Against
Wellington376,4340 00For
Hood River Capital Management LLC349,7740 00For
Goldman Sachs346,1130 00For
Charles Schwab318,5740 00For
Capital Group300,0040 00For
T. Rowe Price296,8380 00For
Vanguard290,9100 00For
DRIEHAUS CAPITAL MANAGEMENT LLC272,8290 00For
PRINCIPAL GLOBAL INVESTORS231,5910 00For
WASATCH ADVISORS LP224,1580 00For
Northern Trust197,3600 00For
BAILLIE GIFFORD & CO LTD188,8040 00For
LORD, ABBETT & CO. LLC172,5000 00For
Candriam S.C.A.0158,766 00Against
BLAIR WILLIAM & CO/IL148,3910 00For
ArrowMark Colorado Holdings LLC140,1970 00For
FRONTIER CAPITAL MANAGEMENT CO LLC136,1473,177 00For
EMERALD ADVISERS, LLC122,2060 00For
Janus Henderson116,2840 00For

Institutional-manager reports, all 342 managers: 14,693,397 for, 863,710 against, 49 abstained, 17,080 not voted. Showing the 25 largest; see all in the interactive database.

11. 4. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for its…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 28,030,696AGAINST: 648,359
Details: description as filed, official tally, votes by 123 asset managers

Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026.

TransMedics Group, Inc.’s own tally for this item (“4. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026, based on the following votes”): 28,030,696 for, 648,359 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Four : The shareholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026, based on the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 123 asset managers below reported 15,305,785 for, 32,817 against, 6,406 abstained.

FOR
FOR: 15,305,785AGAINST: 32,817ABSTAIN: 6,406
Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered pu” at TransMedics Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity4,293,6370 00For
Vanguard3,554,0864,945 00For
BlackRock1,928,2000 00For
MUTUAL FUND SERIES TRUST548,6670 00For
Delaware/Macquarie465,8040 00For
Capital Group300,0040 00For
Charles Schwab278,5180 00For
Royce241,4600 00For
Invesco223,0180 00For
Jackson National194,4640 00For
WASATCH FUNDS TRUST189,8030 00For
T. Rowe Price187,4390 00For
Waddell & Reed175,2560 00For
Hartford153,5870 00For
RBB FUND, INC.148,0040 00For
State Street137,76510 00For
Lord Abbett133,8000 00For
Bridge Builder Trust126,4410 00For
Principal111,7730 00For
Manager Directed Portfolios110,5880 00For
Brighthouse89,8030 6,4060Mixed
Columbia Threadneedle80,6050 00For
Lincoln Financial74,0620 00For
Brown Capital Management Mutual Funds71,3490 00For
TIAA70,7370 00For

Showing the 25 largest of 123 asset managers. See all 123 in the interactive database.

Largest TransMedics Group, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 34,560,911 shares outstanding at the time of that meeting.

Fund voting reports: top TransMedics Group, Inc. shareholders by shares voted on “To approve an amendment to the TransMedics Group, Inc.'s Amended and Restated 2019 Stock…”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 12.42%
2Vanguard 10.30%
3BlackRock 5.58%
4MUTUAL FUND SERIES TRUST 1.59%
5Delaware/Macquarie 1.35%
6Capital Group 0.87%
7Charles Schwab 0.81%
8Royce 0.70%
9Invesco 0.65%
10Jackson National 0.56%
Institutional-manager reports: top TransMedics Group, Inc. shareholders by shares voted on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named…”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 12.50%
2BlackRock 2.84%
3GEODE CAPITAL MANAGEMENT, LLC 2.36%
4NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST 2.29%
5State Street 1.60%
6Invesco 1.32%
7Wellington 1.09%
8Hood River Capital Management LLC 1.01%
9Goldman Sachs 1.00%
10Charles Schwab 0.92%

Reported TransMedics Group, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

TransMedics Group, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 15.32% 13F
FMR (Fidelity) 14.75% 13F
FMR LLC 14.64% DEF14A
Vanguard Portfolio Management 5.64% 13G
Waleed H. Hassanein, M.D. 4.33% DEF14A
State Street 3.82% 13F
Invesco 3.00% 13F
Goldman Sachs 2.51% 13F
Morgan Stanley 1.93% 13F
Dimensional Fund Advisors 1.49% 13F

Percentages above are of 34,560,911 shares outstanding, as reported by TransMedics Group, Inc. on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TransMedics Group, Inc.’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.

At TransMedics Group, Inc.'s shareholder meeting held May 20, 2026, in the 2025-2026 proxy season, 433 asset managers reported how they voted on 11 ballot items in their SEC Form N-PX filings, covering 5,001 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named… — TransMedics Group, Inc.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: TransMedics Group, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 21, 2026.

TransMedics Group, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.